v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   24,681,000      
Beginning balance at Dec. 31, 2024 $ 52,478 $ 2 $ 385,114 $ 16 $ (332,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,680   1,680    
Issuance of common stock upon exercise of warrants (in shares)   426,000      
Issuance of common stock upon exercise of stock options (in shares)   22,000      
Issuance of common stock upon exercise of stock options 21   21    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   63,000      
Private placement, net of transaction costs (in shares)   21,592,000      
Private placement, net of transaction costs 94,548 $ 2 94,546    
Unrealized (loss) gain on investments, net of tax (15)     (15)  
Net Income (Loss) 73,016       73,016
Ending balance (in shares) at Mar. 31, 2025   46,784,000      
Ending balance at Mar. 31, 2025 221,728 $ 4 481,361 1 (259,638)
Beginning balance (in shares) at Dec. 31, 2024   24,681,000      
Beginning balance at Dec. 31, 2024 52,478 $ 2 385,114 16 (332,654)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized (loss) gain on investments, net of tax (7)        
Net Income (Loss) 20,401        
Ending balance (in shares) at Jun. 30, 2025   47,128,000      
Ending balance at Jun. 30, 2025 172,066 $ 4 484,306 9 (312,253)
Beginning balance (in shares) at Mar. 31, 2025   46,784,000      
Beginning balance at Mar. 31, 2025 221,728 $ 4 481,361 1 (259,638)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 3,087   3,087    
Issuance of common stock upon exercise of stock options (in shares)   3,000      
Issuance of common stock upon exercise of stock options 5   5    
Issuance of shares under the employee stock purchase plan (in shares)   16,000      
Issuance of shares under the employee stock purchase plan 24   24    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   325,000      
Private placement, net of transaction costs (171)   (171)    
Unrealized (loss) gain on investments, net of tax 8     8  
Net Income (Loss) (52,615)       (52,615)
Ending balance (in shares) at Jun. 30, 2025   47,128,000      
Ending balance at Jun. 30, 2025 $ 172,066 $ 4 484,306 9 (312,253)
Beginning balance (in shares) at Dec. 31, 2025 47,145,719 47,145,000      
Beginning balance at Dec. 31, 2025 $ 136,311 $ 4 489,437 120 (353,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 2,193   2,193    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   51,000      
Unrealized (loss) gain on investments, net of tax (135)     (135)  
Net Income (Loss) (22,194)       (22,194)
Ending balance (in shares) at Mar. 31, 2026   47,196,000      
Ending balance at Mar. 31, 2026 $ 116,175 $ 4 491,630 (15) (375,444)
Beginning balance (in shares) at Dec. 31, 2025 47,145,719 47,145,000      
Beginning balance at Dec. 31, 2025 $ 136,311 $ 4 489,437 120 (353,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 24,286        
Unrealized (loss) gain on investments, net of tax $ (183)        
Net Income (Loss) $ (38,834)        
Ending balance (in shares) at Jun. 30, 2026 57,009,010 57,009,000      
Ending balance at Jun. 30, 2026 $ 182,925 $ 5 575,067 (63) (392,084)
Beginning balance (in shares) at Mar. 31, 2026   47,196,000      
Beginning balance at Mar. 31, 2026 116,175 $ 4 491,630 (15) (375,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 1,520   1,520    
Issuance of common stock upon exercise of warrants (in shares)   3,210,000      
Issuance of common stock upon exercise of stock options (in shares)   24,000      
Issuance of common stock upon exercise of stock options 56   56    
Issuance of shares under the employee stock purchase plan (in shares)   16,000      
Issuance of shares under the employee stock purchase plan 28   28    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   2,232,000      
Private placement, net of transaction costs (in shares)   4,331,000      
Private placement, net of transaction costs 81,834 $ 1 81,833    
Unrealized (loss) gain on investments, net of tax (48)     (48)  
Net Income (Loss) $ (16,640)       (16,640)
Ending balance (in shares) at Jun. 30, 2026 57,009,010 57,009,000      
Ending balance at Jun. 30, 2026 $ 182,925 $ 5 $ 575,067 $ (63) $ (392,084)